1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (2984)
  2. Meeting Abstract (2527)
  3. Review (137)
  4. Editorial (106)
  5. Book Section (54)
  6. Research Letter (41)
  7. Guidelines (18)
  8. Correspondence (16)
  9. Miscellaneous (15)
  10. Conference Paper (13)
  11. Book Whole (3)
Groups
  1. Human Oncology and Pathogenesis Program (5914)
  2. GSK Faculty (5697)
  3. Department of Medicine (4259)
  4. Department of Pathology and Laboratory Medicine (3037)
  5. Tow Center for Developmental Oncology (TCDO) (2613)
  6. Solid Tumor Oncology Division (2600)

More Groups

People
  1. Marc Ladanyi (1327)
  2. David Solit (779)
  3. Ross Levine (774)
  4. Michael Berger (765)
  5. Nikolaus Schultz (486)
  6. Maria Arcila (426)

More People

Years
  1. 2025 (120)
  2. 2024 (359)
  3. 2023 (402)
  4. 2022 (451)
  5. 2021 (380)
  6. 2020 (457)

More Years

Publications
  1. Journal of Clinical Oncology (636)
  2. Blood (495)
  3. Cancer Research (412)
  4. Modern Pathology (299)
  5. Clinical Cancer Research (268)
  6. Laboratory Investigation (263)

More Publications

Publishers
  1. American Association for Cancer Research (871)
  2. Nature Publishing Group (758)
  3. American Society of Clinical Oncology (702)
  4. American Society of Hematology (541)
  5. Elsevier Inc. (420)
  6. Nature Research (312)

More Publishers

Results (5914)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 1 study of AG-881, an inhibitor of mutant IDH1 and IDH2: Results from the recurrent/progressive glioma population
    Meeting Abstract

    Mellinghoff, I.; Penas-Prado, M.; Peters, K.; Cloughesy, T.; Burris, H.; Maher, E.; Janku, F.; Cote, G.; De La Fuente, M.; Clarke, J.; more...
    Neuro-Oncology (2018)

    Fulltext@MSK | Save
  • Mda5/MAVS signaling is essential for resistance against Aspergillus fumigatus
    Meeting Abstract

    Obar, J. J.; Caffrey, A. K.; Wang, X.; Espinosa, V.; Tang, Y. W.; Hohl, T.; Rivera, A.; Cramer, R.
    Journal of Immunology (2018)

    Fulltext@MSK | Save
  • Characterization of the genetic landscape of low mutation burden malignancies through multi-parallel genomic and immunologic analysis
    Meeting Abstract

    Trippett, T.; Berger, M.; Narendran, A.; Lyden, D.; Kovalchuk, O.; Bodour, S.; Laquaglia, M.; Ambati, S.; Schultz, N.; Roehrl, M.
    European Journal of Cancer (2018)

    Fulltext@MSK | Save
  • Characterization of KDM6A loss in urothelial carcinoma
    Meeting Abstract

    Wise, H. C.; Hu, W.; Gao, P. S.; Ahmad, A.; McPherson, V. A.; Dason, S.; Pietzak, E. J.; Lyer, G.; Al-Ahmadie, H.; Solit, D. B.
    European Journal of Cancer (2018)

    Fulltext@MSK | Save
  • Co-targeting ER and FGFR in patients with ER+/HER2- FGFR amplified (amp) metastatic breast cancer (MBC)
    Meeting Abstract

    Jhaveri, K.; Syed, U.; Wong, S.; D'Andrea, G.; Lake, D.; Goldfarb, S.; Gajria, D.; Ligresti, L.; Rogado, A.; Reis-Filho, J.; more...
    European Journal of Cancer (2018)

    Fulltext@MSK | Save
  • PHF6 mutations are mutually exclusive to TP53 mutations, and define a distinct subgroup of secondary acute myeloid leukemia associated with a primitive stem/progenitor immunophenotype, absent complex karyotype and relatively better outcomes
    Meeting Abstract

    Xiao, W.; Goldberg, A. D.; Ball, B.; Famulare, C.; Pastore, F.; Tallman, M. S.; Zhang, Y.; Arcila, M. E.; Papaemmanuil, E.; Levine, R. L.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Loss of plasmacytoid dendritic cell differentiation is highly predictive for persistent measurable residual disease and poor outcomes in acute myeloid leukemia
    Meeting Abstract

    Xiao, W.; Goldberg, A. D.; Famulare, C.; Delvin, S.; Patel, M.; McGovern, E.; Patel, A.; Schulman, J.; Dunbar, A.; Epstein-Peterson, Z. D.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • The role of HLA-E, polymorphism in acute leukemia patients receiving a 10/10 HLA matched unrelated HSCT
    Meeting Abstract

    Tsamadou, C.; Wang, T.; Furst, D.; Lee, S. J.; Spellman, S. R.; Fleischhauer, K.; Hsu, K. C.; Paczesny, S.; Verneris, M. R.; Neuchel, C.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • MLL-Menin inhibition reverses pre-leukemic progenitor self-renewal induced by NPM1 mutations and prevents AML development
    Meeting Abstract

    Uckelmann, H. J.; Kim, S. M.; Antonissen, N. J. C.; Krivtsov, A. V.; Hatton, C.; McGeehan, G. M.; Levine, R. L.; Vassiliou, G. S.; Armstrong, S. A.
    Blood (2018)

    Fulltext@MSK | Save
  • Intestinal enterococcus is a major risk factor for the development of acute GVHD
    Meeting Abstract

    Stein-Thoeringer, C. K.; Peled, J. U.; Gomes, A. L. C.; Lazrak, A.; Docampo, M. D.; Slingerland, A. E.; Nichols, K.; Shono, Y.; Weber, D.; Sung, A. D.; more...
    Blood (2018)

    Fulltext@MSK | Save